Meso Foundation Participates in Prestigious Conference on Lung Cancer

Mary Hesdorffer, Nurse Practitioner and executive director of the Mesothelioma Applied Research Foundation (Meso Foundation), and Melinda Kotzian, the chief executive officer of the Meso Foundation, are scheduled to attend and participate in the 15th World Conference on Lung Cancer in Sydney, Australia.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Mesothelioma Applied Research Foundation Logo
"I am very grateful to IASLC for this grant," said Ms. Kotzian. "Being able to attend this important conference will allow me to represent the Foundation at a global level, thus helping advance the organization's mission..."

Washington, DC (PRWEB) October 26, 2013

On October 27 – 30, Mary Hesdorffer, Nurse Practitioner and executive director of the Mesothelioma Applied Research Foundation (Meso Foundation), and Melinda Kotzian, the chief executive officer of the Meso Foundation, are scheduled to attend and participate in the 15th World Conference on Lung Cancer in Sydney, Australia, organized by the International Association for the Study of Lung Cancer (IASLC).

They will be representing the Mesothelioma Applied Research Foundation and will be raising awareness of mesothelioma amidst over 7,000 delegates from over 100 countries.

In her capacity as an expert in mesothelioma treatment and care, Ms. Hesdorffer is scheduled to speak at several sessions, including one on the use of social media networks to communicate with and provide support to mesothelioma patients. Ms. Hesdorffer is a pioneer in this area. As a speaker, Ms. Hesdorffer’s travel and lodging costs are entirely covered by IASLC.

Ms. Kotzian’s travel costs are also covered through a grant by IASLC for which she applied earlier this year. She was one of five grant recipients from nonprofit organizations from all over the world awarded travel grants to enable them to attend this event.

"I am very grateful to IASLC for this grant," said Ms. Kotzian. "Being able to attend this important conference will allow me to represent the Foundation at a global level, thus helping advance the organization's mission of developing effective treatments and, ultimately, curing mesothelioma," she added.

The Meso Foundation will also be hosting a booth with information about mesothelioma and programs and services provided by the Foundation.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. Approximately 3,500 Americans are diagnosed with mesothelioma every year and an estimated one-third were exposed in Navy ships or shipyards.

ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)3 non-profit organization dedicated to eradicating mesothelioma and easing the suffering caused by it. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish more effective treatments for mesothelioma and, ultimately, a cure for this rare, but extremely aggressive, cancer. To date, the Foundation has awarded over $8.2 million to research.

More information is available at http://www.curemeso.org.